Diagnostic options · UAE

Genetic tests in Dubai & UAE

Compare available Genetic tests, their listed prices and the information provided for each option. Test selection and preparation should be discussed with your clinician.

Tests in this category

805

Listed price range

600.00–30,000.00 AED

Clinical preparation

Confirm test-specific instructions with your clinician or laboratory.

Compare available tests

Genetic test prices

Showing 766–780 of 805 matching tests.

Genetic diagnostic tests, details, and listed prices
Test and description	Specimen	Typical duration	Price	Options
TEST-6264 TUFM Gene Combined Oxidative Phosphorylation Deficiency Type 4 Genetic Test This test identifies genetic variants in the TUFM gene associated with Combined Oxidative Phosphorylation Deficiency Type 4 (COXPD4).	Whole Blood (3-5 mL) or Buccal Swab (FTA Card)	3 – 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["TUFM gene sequence", "Copy Number Variations (CNV) in TUFM gene"] Parameters [] Preparation ["No fasting required", "No medication adjustments required unless specifically instructed by your doctor"] Indications ["Unexplained mitochondrial encephalopathy", "Lactic acidosis", "Neurodevelopmental regression", "Family history of mitochondrial disorders"] Measurement technique Confirm with laboratory Codes LOINC: 105406-5 ICD-10: E88.49 Clinical summary This test identifies genetic variants in the TUFM gene associated with Combined Oxidative Phosphorylation Deficiency Type 4 (COXPD4).
TEST-4992 TUSC3 Gene Mental Retardation, Autosomal Recessive Type 7 Genetic Test This genetic test identifies pathogenic variants in the TUSC3 gene, which are associated with autosomal recessive mental retardation type 7.	Peripheral Whole Blood (EDTA)	21–28 Days (3–4 Weeks)	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the TUSC3 gene"] Parameters [] Preparation [] Indications ["Differential diagnosis of neurodevelopmental delay", "Family risk assessment for autosomal recessive mental retardation type 7"] Measurement technique Confirm with laboratory Codes LOINC: 94500-0 ICD-10: F78.9, Z14.8, Z82.79 Clinical summary This genetic test identifies pathogenic variants in the TUSC3 gene, which are associated with autosomal recessive mental retardation type 7.
TEST-4911 TYK2 Gene (Autosomal Recessive Immunodeficiency Type 35) Genetic Test This genetic test analyzes the TYK2 gene to identify mutations causing autosomal recessive immunodeficiency type 35.	Peripheral Whole Blood (3–5 mL in EDTA tube); also accepted: extracted DNA (2 µg) or FTA card dried blood spot	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["TYK2 gene coding regions", "TYK2 gene flanking intronic regions"] Parameters [] Preparation ["Informed consent and pre-test genetic counselling are mandatory prior to sample collection"] Indications ["Clinical suspicion of TYK2-related immunodeficiency", "Family history of TYK2-related immunodeficiency", "Recurrent severe infections", "Early-onset atopic dermatitis"] Measurement technique Confirm with laboratory Codes LOINC: 81247-9 ICD-10: D81.8 Clinical summary This genetic test analyzes the TYK2 gene to identify mutations causing autosomal recessive immunodeficiency type 35.
TEST-5473 TYR Gene Albinism (Oculocutaneous Type 1A) Genetic Test This test evaluates the entire TYR gene for mutations associated with oculocutaneous albinism type 1A (OCA1A). It provides a definitive molecular diagnosis.	Whole Blood (EDTA), Extracted DNA, or FTA Card Spot	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the TYR gene"] Parameters [] Preparation ["No fasting required"] Indications ["Suspected diagnosis of oculocutaneous albinism type 1A", "Family history of OCA1A", "Genetic counselling for individuals with albinism features"] Measurement technique Confirm with laboratory Codes LOINC: 93390-5 ICD-10: E70.320, H53.8, Z15.09 Clinical summary This test evaluates the entire TYR gene for mutations associated with oculocutaneous albinism type 1A (OCA1A). It provides a definitive molecular diagnosis.
TEST-5484 TYROBP Gene PLOSL (Nasu‑Hakola Disease) Genetic Test This genetic test evaluates the entire coding region of the TYROBP gene to detect pathogenic variants associated with Nasu‑Hakola disease.	Whole Blood (3–4 mL in DNA tube), Extracted DNA, or FTA Card	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["TYROBP gene coding region", "Pathogenic variants (SNVs, indels, CNVs)"] Parameters [] Preparation [] Indications ["Suspected Nasu‑Hakola disease", "Family history of Nasu‑Hakola disease", "Evaluation of unexplained bone lesions or young-onset dementia"] Measurement technique Confirm with laboratory Codes LOINC: 81321-6 ICD-10: E75.2 Clinical summary This genetic test evaluates the entire coding region of the TYROBP gene to detect pathogenic variants associated with Nasu‑Hakola disease.
TEST-4892 UBE2A Gene Nascimento-Type X-Linked Syndromic Mental Retardation Genetic Test This test evaluates the UBE2A gene for pathogenic variants associated with Nascimento-type X-linked syndromic mental retardation.	Peripheral blood (EDTA tube) or FTA card (dried blood spot)	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["UBE2A gene variants", "Single nucleotide variants", "Small insertions/deletions", "Large copy number changes"] Parameters [] Preparation ["No specific fasting required", "Inform lab of any relevant medications"] Indications ["Suspected Nascimento-type X-linked syndromic mental retardation", "Family history of the condition", "Genetic counselling for at-risk families"] Measurement technique Confirm with laboratory Codes LOINC: 81314-0 ICD-10: Q87.8 Clinical summary This test evaluates the UBE2A gene for pathogenic variants associated with Nascimento-type X-linked syndromic mental retardation.
TEST-3863 UGT1A1 Gene Crigler-Najjar Syndrome Type 1 Genetic Test This genetic test identifies pathogenic variants in the UGT1A1 gene associated with Crigler-Najjar syndrome type 1.	Venous Blood or FTA Card (Dried Blood Spot)	3 to 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the UGT1A1 gene", "Presence of mutations causing Crigler-Najjar syndrome type 1"] Parameters [] Preparation ["Pre-genetic counseling session required", "Document family history of UGT1A1-related jaundice"] Indications ["Suspected Crigler-Najjar syndrome type 1", "Severe neonatal jaundice unresponsive to standard treatment", "Family history of UGT1A1-related disorders"] Measurement technique Confirm with laboratory Codes LOINC: 48807-8 ICD-10: E80.5 Clinical summary This genetic test identifies pathogenic variants in the UGT1A1 gene associated with Crigler-Najjar syndrome type 1.
TEST-3805 UGT1A1 Gene Gilbert Syndrome Genetic Test This genetic test identifies variants in the UGT1A1 gene associated with Gilbert syndrome.	Peripheral whole blood (EDTA) or FTA blood spot card	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["UGT1A1 gene variants", "Promoter TATA box variants", "Exonic variants", "Intronic boundary variants", "Copy number variations (CNV)"] Parameters [] Preparation [] Indications ["Diagnosis of Gilbert syndrome", "Evaluation of mild unconjugated hyperbilirubinemia"] Measurement technique Confirm with laboratory Codes LOINC: 77745-3 ICD-10: E80.4, Z14.8, Z13.79 Clinical summary This genetic test identifies variants in the UGT1A1 gene associated with Gilbert syndrome.
TEST-3794 UGT1A1 Gene Hyperbilirubinemia (Familial Transient Neonatal) Genetic Test This diagnostic test evaluates the UGT1A1 gene for variants associated with familial transient neonatal hyperbilirubinemia.	Peripheral Whole Blood, Dried Blood Spot (FTA Card)	10-14 Business Days (ISO Fast Track)	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["UGT1A1 gene sequence", "Single Nucleotide Variants (SNVs)", "Insertions and Deletions (Indels)", "Copy Number Variations (CNVs)"] Parameters [] Preparation ["No specific fasting required for newborns.", "Inform the lab about any recent blood transfusions."] Indications ["Infants with severe or prolonged neonatal jaundice", "Family history of familial transient neonatal hyperbilirubinemia", "Need for definitive molecular diagnosis to guide management"] Measurement technique Confirm with laboratory Codes LOINC: 21748-8 ICD-10: E80.4 Clinical summary This diagnostic test evaluates the UGT1A1 gene for variants associated with familial transient neonatal hyperbilirubinemia.
TEST-3640 UMOD Gene Medullary Cystic Kidney Disease Type 2 Genetic Test This test identifies mutations in the UMOD gene associated with Medullary Cystic Kidney Disease Type 2.	Whole blood, extracted DNA, or FTA card	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["UMOD gene mutations", "Autosomal dominant tubulointerstitial kidney disease"] Parameters [] Preparation ["No fasting or special preparation needed"] Indications ["Family history of unexplained chronic kidney disease", "Family history of early-onset gout", "Family history of medullary cysts", "Suspicion of Medullary Cystic Kidney Disease Type 2"] Measurement technique Confirm with laboratory Codes LOINC: 92907-8 ICD-10: Q61.5 Clinical summary This test identifies mutations in the UMOD gene associated with Medullary Cystic Kidney Disease Type 2.
TEST-3913 UNC13B Gene Genetic Test for Autism This test evaluates the UNC13B gene for pathogenic variants associated with Autism Spectrum Disorder (ASD). It uses Next-Generation Sequencing (NGS) to identify mutations.	EDTA Whole Blood, Dried Blood Spot, or Extracted DNA	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["UNC13B gene coding region", "Pathogenic variants (SNVs, indels)"] Parameters [] Preparation ["No fasting required", "Provide previous neurodevelopmental assessments", "Provide family history"] Indications ["Suspected genetic cause of Autism Spectrum Disorder", "Family history of ASD", "Risk assessment for family members"] Measurement technique Confirm with laboratory Codes LOINC: 21770-0 ICD-10: F84.0 Clinical summary This test evaluates the UNC13B gene for pathogenic variants associated with Autism Spectrum Disorder (ASD). It uses Next-Generation Sequencing (NGS) to identify mutations.
TEST-3513 UNC45B Gene Cataract Type 43 Genetic Test This genetic test identifies pathogenic variants in the UNC45B gene associated with autosomal dominant congenital cataract type 43.	Peripheral whole blood, FTA card, or extracted DNA	18 – 21 working days	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the UNC45B gene", "Complete coding region of UNC45B"] Parameters [] Preparation ["No specific fasting required", "No specific medication or diet restrictions"] Indications ["Diagnosis of autosomal dominant congenital cataract type 43", "Genetic counselling for families with congenital cataracts"] Measurement technique Confirm with laboratory Codes LOINC: 101188-5 ICD-10: Q12.0 Clinical summary This genetic test identifies pathogenic variants in the UNC45B gene associated with autosomal dominant congenital cataract type 43.
TEST-4902 UNG Gene Immunodeficiency Type 5 with Hyper-IgM (Genetic Test) This genetic test analyzes the UNG gene for pathogenic variants associated with Immunodeficiency Type 5 with Hyper-IgM syndrome.	Peripheral whole blood, extracted DNA, or dried blood spot (FTA card)	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the UNG gene", "Copy number variants (CNVs) in the UNG gene"] Parameters [] Preparation [] Indications ["Suspected Immunodeficiency Type 5 with Hyper-IgM syndrome", "Family history of primary immunodeficiency", "Carrier screening"] Measurement technique Confirm with laboratory Codes LOINC: 32387-5 ICD-10: D82.4 Clinical summary This genetic test analyzes the UNG gene for pathogenic variants associated with Immunodeficiency Type 5 with Hyper-IgM syndrome.
TEST-5013 UPF3B Gene Mental Retardation, X-linked Type 14 (Genetic Test) This diagnostic test evaluates the UPF3B gene for pathogenic variants associated with X-linked intellectual disability type 14 (MRX14). It utilizes Next-Generation Sequencing (NGS)...	Whole Blood (EDTA) or Dried Blood Spot (FTA Card)	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the UPF3B gene", "Full coding region and splice-site coverage"] Parameters [{"name": "Diagnostic Sensitivity", "reference_range": "99.9% (complete coding region + splice sites)"}, {"name": "Methodology", "reference_range": "Next-Generation Sequencing (Illumina platform, 1000x depth)"}, {"name": "ACMG Variant Interpretation", "reference_range": "Full clinical classification with ≥2 genetic counselors review"}] Preparation ["No specific fasting required.", "No medication or diet restrictions unless advised by your physician."] Indications ["Diagnosis of X-linked intellectual disability type 14 (MRX14)", "Establishing recurrence risk in families", "Guiding early intervention strategies"] Measurement technique Confirm with laboratory Codes LOINC: 81768-4 ICD-10: F79, Z13.89, Z14.8 Clinical summary This diagnostic test evaluates the UPF3B gene for pathogenic variants associated with X-linked intellectual disability type 14 (MRX14). It utilizes Next-Generation Sequencing (NGS) to analyze the entire coding region and splice sites.
TEST-4644 UROD Gene Porphyria Cutanea Tarda (PCT) Genetic Test This test evaluates the UROD gene for pathogenic variants associated with Porphyria Cutanea Tarda (PCT). It helps determine if the condition is inherited (familial) or acquired/spo...	Whole Blood (EDTA), Extracted DNA, or FTA Card	3–4 weeks (express available)	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the UROD gene", "Presence of single-nucleotide variants, small deletions, and duplications"] Parameters [] Preparation ["No specific fasting required", "Do not discontinue prescribed medication without consulting your doctor"] Indications ["Suspected familial Porphyria Cutanea Tarda (PCT)", "Differentiation between familial and acquired PCT", "Family screening for PCT"] Measurement technique Confirm with laboratory Codes LOINC: 90777-8 ICD-10: E80.1 Clinical summary This test evaluates the UROD gene for pathogenic variants associated with Porphyria Cutanea Tarda (PCT). It helps determine if the condition is inherited (familial) or acquired/sporadic.

Category overview

Genetic: overview

Unlocking the blueprint of your DNA provides profound, proactive insights into your family’s future and personal health risks. Integrated within our advanced Biochemistry and molecular services, specialized Genetic testing evaluates inherited traits, metabolic predispositions, and carrier statuses. Utilizing cutting-edge diagnostic technology, comprehensive genetic screening offers the vital clarity needed to safely guide tailored medical strategies and family planning. As an undisputed leader in innovation among diagnostic labs in Dubai and the UAE, DNA Labs guarantees the highest standards of strict patient confidentiality, unparalleled diagnostic precision, and rapid reporting. Empower your health decisions with certainty—book your genetic testing in UAE, coordinate a secure sample collection, or connect with our specialized genetics team today.

Before booking

Use the test details as a conversation starter

The right diagnostic option depends on your reason for testing and individual circumstances. Check the listed specimen and timing, then confirm any preparation requirements with the ordering clinician or laboratory before collection.